These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 6336039)

  • 1. [Immunological analysis by using animal models of multiple sclerosis--acute and chronic relapsing EAE].
    Tabira T
    Rinsho Shinkeigaku; 1984 Dec; 24(12):1229-31. PubMed ID: 6336039
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunologic studies of chronic relapsing EAE in guinea pigs: similarities to multiple sclerosis.
    Mehta PD; Lassmann H; Wisniewski HM
    J Immunol; 1981 Jul; 127(1):334-8. PubMed ID: 7240747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple sclerosis: human model for EAE?
    Hohlfeld R
    Eur J Immunol; 2009 Aug; 39(8):2036-9. PubMed ID: 19672899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active and passively induced experimental autoimmune encephalomyelitis in common marmosets: a new model for multiple sclerosis.
    Massacesi L; Genain CP; Lee-Parritz D; Letvin NL; Canfield D; Hauser SL
    Ann Neurol; 1995 Apr; 37(4):519-30. PubMed ID: 7717689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The generation of the relapse in chronic relapsing experimental allergic encephalomyelitis and multiple sclerosis--parallels and differences.
    Suckling AJ; Kirby JA; Wilson NR; Rumsby MG
    Prog Clin Biol Res; 1984; 146():7-12. PubMed ID: 6609376
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapeutic activity of malononitrilamides (MNA 279 and MNA 715) on acute and chronic, relapsing, experimental, allergic encephalomyelitis (EAE).
    Schorlemmer HU; Bartlett RR
    Drugs Exp Clin Res; 1997; 23(5-6):175-81. PubMed ID: 9515227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proceedings: Immunogenetic aspects of demyelinating disease.
    Arnason BG; Chelmicka-Szorc E
    Neurology; 1975 May; 25(5):489. PubMed ID: 1079582
    [No Abstract]   [Full Text] [Related]  

  • 8. Oral glatiramer acetate in experimental autoimmune encephalomyelitis: clinical and immunological studies.
    Teitelbaum D; Aharoni R; Klinger E; Kreitman R; Raymond E; Malley A; Shofti R; Sela M; Arnon R
    Ann N Y Acad Sci; 2004 Dec; 1029():239-49. PubMed ID: 15681762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biology of disease. Analysis of autoimmune demyelination: its impact upon multiple sclerosis.
    Raine CS
    Lab Invest; 1984 Jun; 50(6):608-35. PubMed ID: 6202955
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of cervical lymph nodes in autoimmune encephalomyelitis in the Lewis rat.
    Phillips MJ; Needham M; Weller RO
    J Pathol; 1997 Aug; 182(4):457-64. PubMed ID: 9306968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Activation of T cells in experimental autoimmune encephalomyelitis and multiple sclerosis].
    Rodríguez-Rodríguez Y; Suárez-Luis I
    Rev Neurol; 2003 Apr 1-15; 36(7):649-52. PubMed ID: 12666047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental allergic encephalomyelitis as an animal model for multiple sclerosis].
    Lukinović-Skudar V; Taradi SK; Andreis I; Zupancić V; Taradi M
    Lijec Vjesn; 2001; 123(3-4):81-8. PubMed ID: 11488222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematopoietic stem cell transplantation in multiple sclerosis: experimental evidence to rethink the procedures.
    Karussis D; Slavin S
    J Neurol Sci; 2004 Aug; 223(1):59-64. PubMed ID: 15261562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex-dimorphic changes in neuroactive steroid levels after chronic experimental autoimmune encephalomyelitis.
    Caruso D; D'Intino G; Giatti S; Maschi O; Pesaresi M; Calabrese D; Garcia-Segura LM; Calza L; Melcangi RC
    J Neurochem; 2010 Aug; 114(3):921-32. PubMed ID: 20492360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conclusion: is myelin basic protein the right antigen and experimental allergic encephalomyelitis the right model for multiple sclerosis?
    Alvord EC
    Prog Clin Biol Res; 1984; 146():503-8. PubMed ID: 6201920
    [No Abstract]   [Full Text] [Related]  

  • 16. Antigen presentation in the CNS by myeloid dendritic cells drives progression of relapsing experimental autoimmune encephalomyelitis.
    Miller SD; McMahon EJ; Schreiner B; Bailey SL
    Ann N Y Acad Sci; 2007 Apr; 1103():179-91. PubMed ID: 17376826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The nature of factors in chronic relapsing EAE and MS sera which induce myelinotoxicity and cellular changes in organ culture.
    Bradbury K; Suckling AJ
    Prog Clin Biol Res; 1984; 146():193-8. PubMed ID: 6201890
    [No Abstract]   [Full Text] [Related]  

  • 18. Virtues and pitfalls of EAE for the development of therapies for multiple sclerosis.
    Steinman L; Zamvil SS
    Trends Immunol; 2005 Nov; 26(11):565-71. PubMed ID: 16153891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunology of multiple sclerosis and its animal model, experimental allergic encephalomyelitis.
    Owens T; Sriram S
    Neurol Clin; 1995 Feb; 13(1):51-73. PubMed ID: 7739505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroimmunology of multiple sclerosis and experimental allergic encephalomyelitis.
    Stuerzebecher S; Martin R
    Neuroimaging Clin N Am; 2000 Nov; 10(4):649-68 ,vii-viii. PubMed ID: 11359717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.